PENSION AND OTHER POSTRETIREMENT BENEFITS (Tables)
|
12 Months Ended |
Nov. 02, 2025 |
| PENSION AND OTHER POSTRETIREMENT BENEFITS |
|
| Schedule of Components of Net Periodic Pension and OPEB (Benefit) Cost |
The components of net periodic pension benefit and the related assumptions consisted of the following: | | | | | | | | | | | | | 2025 | | 2024 | | 2023 | | Pensions: | | | | | | | | | | | Service cost | | $ | 252 | | $ | 230 | | $ | 246 | | Interest cost | | | 517 | | | 545 | | | 533 | | Expected return on plan assets | | | (1,005) | | | (967) | | | (878) | | Amortization of actuarial (gain) loss | | | 5 | | | 3 | | | (13) | | Amortization of prior service cost | | | 39 | | | 40 | | | 38 | | Settlements/curtailments | | | 25 | | | 38 | | | 37 | | Net benefit | | $ | (167) | | $ | (111) | | $ | (37) | | Weighted-average assumptions: | | | | | | | | | | | Discount rates – service cost | | | 4.9% | | | 5.8% | | | 5.2% | | Discount rates – interest cost | | | 4.9% | | | 5.7% | | | 5.1% | | Rate of compensation increase | | | 4.3% | | | 3.8% | | | 3.8% | | Expected long-term rates of return | | | 7.2% | | | 7.0% | | | 6.3% | | Interest crediting rate – U.S. cash balance plans | | | 4.2% | | | 4.8% | | | 4.3% | |
The components of net periodic OPEB cost and the assumptions related to the cost consisted of the following: | | | | | | | | | | | | | 2025 | | 2024 | | 2023 | | OPEB: | | | | | | | | | | | Service cost | | $ | 17 | | $ | 17 | | $ | 27 | | Interest cost | | | 158 | | | 174 | | | 176 | | Expected return on plan assets | | | (113) | | | (108) | | | (117) | | Amortization of actuarial gain | | | (44) | | | (54) | | | (59) | | Amortization of prior service credit | | | (4) | | | (4) | | | (3) | | Net cost | | $ | 14 | | $ | 25 | | $ | 24 | | Weighted-average assumptions: | | | | | | | | | | | Discount rates – service cost | | | 5.7% | | | 6.7% | | | 6.1% | | Discount rates – interest cost | | | 5.0% | | | 5.9% | | | 5.4% | | Expected long-term rates of return | | | 5.3% | | | 5.6% | | | 5.7% | |
|
| Schedule of Benefit Plan Obligations, Funded Status, and the Assumptions Related to the Obligations |
The benefit plan obligations, funded status, and the assumptions related to the obligations at November 2, 2025, and October 27, 2024, follow: | | | | | | | | | | | | | | | | Pensions | | OPEB | | | | 2025 | | 2024 | | 2025 | | 2024 | | Change in benefit obligations: | | | | | | | | | | | | | | Beginning of year balance | | $ | (11,077) | | $ | (9,928) | | $ | (3,362) | | $ | (3,029) | | Service cost | | | (252) | | | (230) | | | (17) | | | (17) | | Interest cost | | | (517) | | | (545) | | | (158) | | | (174) | | Actuarial gain (loss) | | | 197 | | | (1,097) | | | (25) | | | (385) | | Benefits paid | | | 752 | | | 746 | | | 280 | | | 263 | | Health care subsidies | | | | | | | | | (24) | | | (22) | | Foreign exchange and other | | | (99) | | | (23) | | | (2) | | | 2 | | End of year balance | | | (10,996) | | | (11,077) | | | (3,308) | | | (3,362) | | | | | | | | | | | | | | | | Change in plan assets (fair value): | | | | | | | | | | | | | | Beginning of year balance | | | 13,080 | | | 12,004 | | | 2,171 | | | 2,028 | | Plan assets actual gain (loss) | | | 849 | | | 1,703 | | | 203 | | | 259 | | Employer contribution | | | 107 | | | 96 | | | 671 | | | 145 | | Benefits paid | | | (752) | | | (746) | | | (280) | | | (263) | | Foreign exchange and other | | | 74 | | | 23 | | | 2 | | | 2 | | End of year balance | | | 13,358 | | | 13,080 | | | 2,767 | | | 2,171 | | Funded status | | $ | 2,362 | | $ | 2,003 | | $ | (541) | | $ | (1,191) | | | | | | | | | | | | | | | | Weighted-average assumptions: | | | | | | | | | | | | | | Discount rates | | | 5.2% | | | 5.1% | | | 5.1% | | | 5.2% | | Rate of compensation increase | | | 3.9% | | | 4.3% | | | | | | | | Interest crediting rate – U.S. cash balance plans | | | 4.2% | | | 4.1% | | | | | | | |
|
| Schedule of Weighted-Average Health Care Cost Trend Rates |
The weighted-average annual rates of increase in the per capita cost of covered health care benefits (the health care cost trend rates) for medical and prescription drug claims for pre- and post-65 age groups used to determine the November 2, 2025, and October 27, 2024, accumulated postretirement benefit obligations were as follows: | | | | | | | | 2025 | | 2024 | | Initial year | | 18.1% (2025 to 2026) | | 16.9% (2024 to 2025) | | Second year | | 9.9% (2026 to 2027) | | 11.5% (2025 to 2026) | | Ultimate | | 4.7% (2034 to 2035) | | 4.7% (2033 to 2034) | |
An increase in Medicare Advantage premiums impacted the weighted-average annual rates of increase for the initial year in 2025 and 2024.
|
| Schedule of Information Related to Pension Plans Benefit Obligations |
Information related to pension plans benefit obligations at November 2, 2025, and October 27, 2024, follows: | | | | | | | | | | 2025 | | 2024 | | Total accumulated benefit obligations for all plans | | $ | 10,424 | | $ | 10,441 | | Plans with accumulated benefit obligation exceeding fair value of plan assets: | | | | | | | | Accumulated benefit obligations | | | 1,405 | | | 1,405 | | Fair value of plan assets | | | 983 | | | 920 | | Plans with projected benefit obligation exceeding fair value of plan assets: | | | | | | | | Projected benefit obligations | | | 1,542 | | | 1,541 | | Fair value of plan assets | | | 1,021 | | | 951 | |
|
| Schedule of Amounts Recognized in the Balance Sheet |
The pension and OPEB amounts recognized in the balance sheet at November 2, 2025, and October 27, 2024, consisted of the following: | | | | | | | | | | | | | | | | Pensions | | OPEB | | | | 2025 | | 2024 | | 2025 | | 2024 | | Noncurrent asset | | $ | 2,883 | | $ | 2,593 | | $ | 390 | | $ | 328 | | Less: Current liability | | | 56 | | | 66 | | | 41 | | | 39 | | Less: Noncurrent liability | | | 465 | | | 524 | | | 890 | | | 1,480 | | Total | | $ | 2,362 | | $ | 2,003 | | $ | (541) | | $ | (1,191) | |
The retirement benefits and other liabilities recognized in the balance sheet at November 2, 2025, and October 27, 2024, consisted of the following: | | | | | | | | | | 2025 | | 2024 | | Deferred compensation – current | | $ | 23 | | $ | 28 | | Deferred compensation and other – noncurrent | | | 235 | | | 217 | | Pensions and OPEB – current | | | 97 | | | 105 | | Pensions and OPEB – noncurrent | | | 1,355 | | | 2,004 | | Total | | $ | 1,710 | | $ | 2,354 | |
|
| Schedule of Amounts Recognized in Accumulated Other Comprehensive Income - Pretax |
The amounts recognized in accumulated other comprehensive income ‒ pretax at November 2, 2025, and October 27, 2024, consisted of the following: | | | | | | | | | | | | | | | | Pensions | | OPEB | | | | 2025 | | 2024 | | 2025 | | 2024 | | Net actuarial (gain) loss | | $ | 1,953 | | $ | 2,011 | | $ | (653) | | $ | (632) | | Prior service cost | | | 272 | | | 329 | | | 8 | | | 2 | | Total | | $ | 2,225 | | $ | 2,340 | | $ | (645) | | $ | (630) | |
|
| Schedule of Future Benefits Expected to be Paid from the Benefit Plans |
The expected future benefit payments at November 2, 2025, were as follows: | | | | | | | | | | Pensions | | OPEB* | | 2026 | | $ | 750 | | $ | 256 | | 2027 | | | 727 | | | 262 | | 2028 | | | 725 | | | 267 | | 2029 | | | 724 | | | 269 | | 2030 | | | 718 | | | 275 | | 2031 to 2035 | | | 3,585 | | | 1,321 | |
* Net of prescription drug group benefit subsidy under Medicare Part D.
|
| Schedule of Fair Values of Pension Plan and OPEB Health Care Assets and Target Asset Allocations |
The fair values of the pension plan assets at November 2, 2025, follow: | | | | | | | | | | | | | Total | | Level 1 | | Level 2 | | Cash and short-term investments | | $ | 275 | | $ | 272 | | $ | 3 | | Equity: | | | | | | | | | | | U.S. equity securities | | | 479 | | | 468 | | | 11 | | International equity securities and funds | | | 249 | | | 241 | | | 8 | | Fixed Income: | | | | | | | | | | | Government and agency securities | | | 1,279 | | | 860 | | | 419 | | Corporate debt securities | | | 5,543 | | | | | | 5,543 | | Mortgage-backed securities | | | 254 | | | | | | 254 | | Other investments | | | 55 | | | 31 | | | 24 | | Derivative contracts – assets | | | 95 | | | 57 | | | 38 | | Derivative interest rate contracts – liabilities | | | (75) | | | (3) | | | (72) | | Receivables and payables | | | (264) | | | (264) | | | | | Securities lending collateral | | | 507 | | | | | | 507 | | Securities lending liability | | | (507) | | | | | | (507) | | Securities sold short | | | (107) | | | (105) | | | (2) | | Total of Level 1 and Level 2 assets | | | 7,783 | | $ | 1,557 | | $ | 6,226 | | Investments at net asset value: | | | | | | | | | | | Short-term investments | | | 503 | | | | | | | | U.S. equity funds | | | 211 | | | | | | | | International equity funds | | | 259 | | | | | | | | Fixed income funds | | | 1,593 | | | | | | | | Real estate funds | | | 316 | | | | | | | | Hedge funds | | | 481 | | | | | | | | Private equity | | | 1,037 | | | | | | | | Venture capital | | | 1,121 | | | | | | | | Other investments | | | 54 | | | | | | | | Total net assets | | $ | 13,358 | | | | | | | |
The fair values of the OPEB health care assets at November 2, 2025, follow: | | | | | | | | | | | | | Total | | Level 1 | | Level 2 | | Cash and short-term investments | | $ | 104 | | $ | 104 | | | | | Equity securities | | | 73 | | | 67 | | $ | 6 | | Fixed Income: | | | | | | | | | | | Government and agency securities | | | 673 | | | 621 | | | 52 | | Corporate debt securities | | | 658 | | | | | | 658 | | Mortgage-backed securities | | | 110 | | | | | | 110 | | Other | | | (28) | | | (30) | | | 2 | | Securities lending collateral | | | 105 | | | | | | 105 | | Securities lending liability | | | (105) | | | | | | (105) | | Total of Level 1 and Level 2 assets | | | 1,590 | | $ | 762 | | $ | 828 | | Investments at net asset value: | | | | | | | | | | | U.S. equity funds | | | 115 | | | | | | | | International equity funds | | | 75 | | | | | | | | Fixed income funds | | | 436 | | | | | | | | Real estate funds | | | 106 | | | | | | | | Hedge funds | | | 104 | | | | | | | | Private equity | | | 153 | | | | | | | | Venture capital | | | 165 | | | | | | | | Other investments | | | 23 | | | | | | | | Total net assets | | $ | 2,767 | | | | | | | |
The fair values of the pension plan assets at October 27, 2024, follow: | | | | | | | | | | | | | Total | | Level 1 | | Level 2 | | Cash and short-term investments | | $ | 411 | | $ | 399 | | $ | 12 | | Equity: | | | | | | | | | | | U.S. equity securities | | | 451 | | | 440 | | | 11 | | International equity securities and funds | | | 238 | | | 232 | | | 6 | | Fixed Income: | | | | | | | | | | | Government and agency securities | | | 1,250 | | | 932 | | | 318 | | Corporate debt securities | | | 4,956 | | | | | | 4,956 | | Mortgage-backed securities | | | 177 | | | | | | 177 | | Other investments | | | 57 | | | 36 | | | 21 | | Derivative contracts – assets | | | 130 | | | 7 | | | 123 | | Derivative interest rate contracts – liabilities | | | (161) | | | (119) | | | (42) | | Receivables, prepaids, and payables | | | (171) | | | (171) | | | | | Securities lending collateral | | | 662 | | | | | | 662 | | Securities lending liability | | | (662) | | | | | | (662) | | Securities sold short | | | (94) | | | (92) | | | (2) | | Total of Level 1 and Level 2 assets | | | 7,244 | | $ | 1,664 | | $ | 5,580 | | Investments at net asset value: | | | | | | | | | | | Short-term investments | | | 492 | | | | | | | | U.S. equity funds | | | 174 | | | | | | | | International equity funds | | | 194 | | | | | | | | Fixed income funds | | | 1,649 | | | | | | | | Real estate funds | | | 385 | | | | | | | | Hedge funds | | | 457 | | | | | | | | Private equity | | | 1,219 | | | | | | | | Venture capital | | | 1,219 | | | | | | | | Other investments | | | 47 | | | | | | | | Total net assets | | $ | 13,080 | | | | | | | |
The fair values of the OPEB health care assets at October 27, 2024, follow: | | | | | | | | | | | | | Total | | Level 1 | | Level 2 | | Cash and short-term investments | | $ | 77 | | $ | 77 | | | | | Fixed Income: | | | | | | | | | | | Government and agency securities | | | 606 | | | 561 | | $ | 45 | | Corporate debt securities | | | 551 | | | | | | 551 | | Mortgage-backed securities | | | 92 | | | | | | 92 | | Other | | | 11 | | | 7 | | | 4 | | Securities lending collateral | | | 167 | | | | | | 167 | | Securities lending liability | | | (167) | | | | | | (167) | | Total of Level 1 and Level 2 assets | | | 1,337 | | $ | 645 | | $ | 692 | | Investments at net asset value: | | | | | | | | | | | U.S. equity funds | | | 163 | | | | | | | | International equity funds | | | 84 | | | | | | | | Fixed income funds | | | 348 | | | | | | | | Real estate funds | | | 77 | | | | | | | | Hedge funds | | | 71 | | | | | | | | Private equity | | | 41 | | | | | | | | Venture capital | | | 41 | | | | | | | | Other investments | | | 9 | | | | | | | | Total net assets | | $ | 2,171 | | | | | | | |
The target asset allocations as of November 2, 2025, are as follows: | | | | | | | | Pension | | Health Care | | | | Assets | | Assets | | Equity | | 8% | | 10% | | Debt | | 66% | | 70% | | Real estate | | 3% | | 3% | | Other investments | | 23% | | 17% | |
|